Results 81 to 90 of about 8,420 (193)

GEANT4 Target Simulations for Low Energy Medical Applications [PDF]

open access: yes, 2013
The GEANT4 code offers an extensive set of hadronic models for various projectiles and energy ranges. These models include theoretical, parameterized and, for low energy neutrons, data driven models.
Barlow, Roger   +4 more
core  

Imaging Hepatocellular Carcinoma With 68Ga-Citrate PET: First Clinical Experience. [PDF]

open access: yes, 2017
While cross-sectional imaging with computed tomography (CT) and magnetic resonance imaging is the primary method for diagnosing hepatocellular carcinoma (HCC), they provide little biological insight into this molecularly heterogeneous disease.
Aggarwal, Rahul   +7 more
core   +2 more sources

Potential Targets and Biomarkers of Radionuclide Therapy in Breast Cancer

open access: yesCancer Innovation, Volume 5, Issue 1, February 2026.
Potential biomarkers for the development of targeted radionuclide therapy that can be employed in the treatment of breast cancer have been summarised in the review. They include receptor markers of ER, PR and HER2, as well as other markers of Trop2, PD‐1, EGFR, GRPR and PSMA.
Yujing Tan   +3 more
wiley   +1 more source

PET imaging of colon cancer CD73 expression using cysteine site-specific 89Zr-labeled anti-CD73 antibody

open access: yesScientific Reports
CD73 is a cell-surface ectoenzyme that hydrolyzes the conversion of extracellular adenosine monophosphate to adenosine, which in turn can promote resistance to immune checkpoint blockade therapy.
Kyung-Ho Jung   +6 more
doaj   +1 more source

SUBDUE‐3: SUB‐urothelial DUrvalumab‐89zirconium injEction; a phase 0 biodistribution study protocol

open access: yes
BJU International, EarlyView.
Kevin G. Keane   +9 more
wiley   +1 more source

Noninvasive imaging of amyloid‐beta and tau in rodent and nonhuman primate models

open access: yesVIEW, Volume 7, Issue 1, February 2026.
Imaging of amyloid‐beta plaque and tau accumulation in rodent and nonhuman primate model of Alzheimer's disease. Created in BioRender. Ni R. 2026. https://BioRender.com/a97h5ec Abstract Neurodegenerative diseases are characterized by the aberrant accumulation of protein aggregates.
Ruiqing Ni, Axel Rominger
wiley   +1 more source

A proof-of-concept study to investigate the radiolabelling of human mesenchymal and hematopoietic stem cells with [89Zr]Zr-Df-Bz-NCS

open access: yesEJNMMI Radiopharmacy and Chemistry
Background The transplantation of hematopoietic stem and progenitor cells (HSPCs) or mesenchymal stromal/stem cells (MSCs) for the treatment of a wide variety of diseases has been studied extensively.
Maryke Kahts   +8 more
doaj   +1 more source

PSMA PET‐directed radiotherapy for prostate cancer: From precision planning to future innovations

open access: yesVIEW, Volume 7, Issue 1, February 2026.
Prostate‐specific membrane antigen (PSMA) positron emission tomography (PET) imaging enables highly sensitive detection of prostate cancer recurrence and precise lesion mapping. This review summarizes current evidence and emerging applications of PSMA PET in radiotherapy, including diagnostic staging, target delineation, adaptive planning, and outcome ...
Wenpeng Huang   +7 more
wiley   +1 more source

Zirconium-89-labelled rituximab PET-CT in orbital inflammatory disease

open access: yesEJNMMI Research, 2019
Background Orbital inflammatory diseases are a heterogenic group of conditions that often entail a difficult diagnostic process and many patients are treatment resistant.
Kamil G. Laban   +3 more
doaj   +1 more source

Synthesis and Feasibility Evaluation of a new Trastuzumab Conjugate Integrated with Paclitaxel and 89Zr for Theranostic Application Against HER2‐Expressing Breast Cancers

open access: yesChemistryOpen, 2019
The preparation and in vitro evaluation of a theranostic conjugate composed of trastuzumab, paclitaxel (PTX), and deferoxamine (DFO)‐chelated 89Zr have been reported.
Dr. Joo Hee Jang   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy